Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer1

This publication has 12 references indexed in Scilit:

• Cancer Statistics, 2001
  CA: A Cancer Journal for Clinicians, 2001
• Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): Analysis of failures in a phase III study (RTOG 9410)
  International Journal of Radiation Oncology*Biology*Physics, 2000
• A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
  Published by Elsevier ,2000
• Altered fractionation trials in head and neck cancer
  Seminars in Radiation Oncology, 1998
• The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma
  Cancer, 1998
• Altered Fractionation in Radiation Therapy for Squamous-Cell Carcinoma of the Head and Neck
  Cancer Investigation, 1998
• Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial
  JNCI Journal of the National Cancer Institute, 1996
• Pilot Study of Accelerated Hyperfractionated Thoracic Radiation Therapy Plus Concomitant Etoposide and Cisplatin Chemotherapy in Patients With Unresectable Stage III Non-Small-Cell Carcinoma of the Lung
  JNCI Journal of the National Cancer Institute, 1993
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
  British Journal of Cancer, 1977
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958